Unlock AI-driven, actionable R&D insights for your next breakthrough.

Ethylene Vinyl Acetate Foam: Comprehensive Analysis Of Composition, Processing, And Advanced Applications

FEB 26, 202657 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
Ethylene vinyl acetate foam represents a versatile class of closed-cell elastomeric materials combining the processability of thermoplastics with rubber-like resilience, widely deployed in footwear midsoles, automotive interiors, sports equipment, and medical devices. This copolymer foam derives its tunable properties from the ethylene-to-vinyl acetate ratio, crosslinking chemistry, and foaming agent selection, enabling density ranges from ultra-soft (0.01 g/cm³) to structural grades (0.18 g/cm³) with hardness spanning 10–60 Shore 00 4. Recent innovations focus on biodegradable formulations 3, eco-friendly blowing agents 7, and dynamic crosslinking for recyclability 20, addressing environmental concerns while maintaining mechanical performance.
Want to know more material grades? Try Patsnap Eureka Material.

Molecular Composition And Structural Characteristics Of Ethylene Vinyl Acetate Foam

Ethylene vinyl acetate foam is synthesized from EVA copolymers wherein the vinyl acetate (VA) content critically governs final properties. The VA content typically ranges from 5–25 wt%, with higher concentrations (>15 wt%) imparting enhanced flexibility and rubber-like behavior, while lower VA levels (<10 wt%) yield harder, more crystalline structures 12. The copolymer architecture consists of ethylene segments providing crystallinity and mechanical strength, interspersed with vinyl acetate units contributing polarity, adhesion, and compatibility with fillers 1.

Key compositional parameters include:

  • Melt Flow Index (MFI): EVA resins for foaming applications exhibit MFI values >1 g/10 min (ASTM D1238, 190°C/2.16 kg), with optimal ranges of 1.5–10 g/10 min ensuring adequate processability without sacrificing cell structure integrity 12. Ultra-soft foam formulations may employ resins with MFI 0.1–1.0 g/10 min to control expansion kinetics 16.

  • Vinyl Acetate Content: Foams for medical and healthcare applications utilize 18–28 wt% VA to achieve biocompatibility and softness (Shore A 15–18) 1, whereas footwear midsoles often employ 10–18 wt% VA balancing cushioning with durability 14. The VA content directly influences the decomposition temperature of crosslinking agents and the foam's thermal stability window 10.

  • Molecular Weight Distribution: Advanced characterization via GPC-FTIR reveals that foams with superior impact resistance exhibit controlled molecular weight distributions, where the slope P of carbonyl-to-methylene absorption ratio versus log(molecular weight) falls within 0.00 ≤ P ≤ 1.40, and the methyl-to-methylene ratio Q ranges 23.0–30.0 19. This distribution ensures uniform crosslinking density and minimizes cell coalescence during expansion.

  • Crystallinity And Morphology: Solid-state NMR analysis (Solid Echo method) of high-performance EVA foams shows a three-component mobility model: a rigid crystalline phase (α-component, 28–36% composition ratio, relaxation time Tα ~msec scale), an intermediate amorphous phase (β-component), and a highly mobile phase (γ-component, Tγ 375–600 µs) 10. This hierarchical structure provides both elastic recovery and energy dissipation under cyclic loading.

The molecular architecture is further tailored through copolymer blending. Blending EVA with ethylene methyl acrylate (EMA) at ratios of 50–90:10–50 parts by weight addresses EVA's inherent high shrinkage and poor injection moldability 1. EMA contributes superior flow characteristics and dimensional stability, reducing post-molding shrinkage from >5% to <2% while maintaining biocompatibility 1. Similarly, incorporation of polyamide-polyether block copolymers (PEBA) at 5–20 wt% enhances flexibility, resilience, and working temperature range, overcoming traditional EVA foam limitations in low-temperature flexibility and durability 2.

Formulation Components And Additive Systems For Ethylene Vinyl Acetate Foam

EVA foam formulations are multi-component systems where each additive serves a precise function in controlling rheology, crosslinking kinetics, cell nucleation, and final properties. A representative formulation comprises 1:

Matrix Resin (100 parts by weight total):

  • EVA copolymer: 50–90 pbw
  • EMA or other polyolefin modifier: 10–50 pbw

Functional Additives (per 100 pbw matrix):

  • Processing Aid (1–3 pbw): Typically low-molecular-weight polyethylene waxes or ethylene-bis-stearamide, reducing melt viscosity and improving filler dispersion without compromising cell structure 1.

  • Foaming Agent (3–10 pbw): Chemical blowing agents dominate EVA foam production. Azodicarbonamide (ADC) is the industry standard, decomposing at 195–215°C to release N₂ and CO₂ with gas yields of ~220 mL/g 5. However, ADC generates toxic residues and requires high processing temperatures. Recent eco-friendly alternatives include hydrazide-based agents (e.g., p-toluenesulfonyl hydrazide) decomposing at 110–155°C, reducing energy consumption by 20–30% and eliminating carcinogenic emissions 17. Sodium bicarbonate/citric acid systems offer non-toxic foaming for food-contact applications but yield lower expansion ratios (gas yield ~120 mL/g) 7.

  • Crosslinking Agent (0.6–4 pbw): Organic peroxides such as dicumyl peroxide (DCP, decomposition temperature 170–180°C) or 2,5-dimethyl-2,5-di(tert-butylperoxy)hexane initiate free-radical crosslinking of EVA chains 3. The peroxide concentration critically balances foam expansion and network formation: insufficient crosslinking (<0.6 pbw) causes cell collapse, while excessive crosslinking (>4 pbw) restricts expansion and increases density 4. The crosslinking reaction generates a three-dimensional network with gel content typically 60–85%, measured by solvent extraction (ASTM D2765) 15.

  • Foaming Aid/Activator (0.5–2 pbw): Zinc oxide (ZnO, 3–5 pbw) and zinc stearate (0.5–1 pbw) catalyze peroxide decomposition and regulate foam cell size by acting as nucleation sites 1. Amine-based activators (e.g., diethylenetriamine) lower ADC decomposition temperature by 10–15°C, enabling co-decomposition with peroxides and improving cell uniformity 17.

  • Filler (4–80 pbw): Calcium carbonate (CaCO₃, median particle size 2–5 µm) is the primary filler, enhancing dimensional stability, reducing cost, and serving as cell nucleation sites 1. Talc (4–6 pbw) improves mold release and surface finish 1. High-filler loadings (40–80 pbw) are employed in shock-absorbing pads for flooring and footwear, where the filler network contributes to compression set resistance 13. Organically modified layered clays (0.1–50 pbw) improve dimensional stability and reduce shrinkage by 30–50% through nanoconfinement effects, though excessive loading (>10 pbw) may hinder cell expansion 9.

  • Lubricant (4–20 pbw): Stearic acid (1.5–3 pbw) and paraffin wax reduce melt viscosity and prevent sticking to molds during compression or injection molding 1.

  • Biodegradation Agents (1.5–5 pbw, optional): For environmentally responsive foams, photodegradation agents (e.g., titanium dioxide nanoparticles), chemical degradation promoters (pro-oxidants like cobalt stearate), or biodegradation enhancers (polyhydroxybutyrate, PHB, 30–40 wt%) are incorporated 3,5. PHB-modified EVA foams exhibit 40–60% mass loss after 180 days in composting conditions (ASTM D6400) while retaining initial mechanical properties during service life 3.

Formulation Example For Ultra-Soft Ethylene Vinyl Acetate Foam 4:

  • EVA (VA content 18–28 wt%, MFI 2–6 g/10 min): 100 pbw
  • Blowing agent (ADC or hydrazide blend): 8–15 pbw
  • Crosslinking agent (DCP): 0.5–1.5 pbw
  • ZnO: 3 pbw
  • Stearic acid: 1 pbw
  • CaCO₃: 5–10 pbw

This formulation yields foams with density 0.01–0.06 g/cm³, hardness 10–30 Shore 00, and compression set <15% (ASTM D395, 22 h at 70°C) 4.

Processing Technologies And Manufacturing Methods For Ethylene Vinyl Acetate Foam

EVA foam production employs several thermomechanical processes, each suited to specific product geometries and performance requirements.

Compression Molding (Slab Stock Production)

Compression molding in large steam-heated presses (platen sizes up to 2 m × 4 m) is the dominant method for footwear midsole and mat production 15. The process involves:

  1. Compounding: EVA resin, additives, and fillers are batch-mixed in internal mixers (Banbury or Intermix) at 80–120°C for 8–15 minutes to achieve homogeneous dispersion without premature crosslinking 15.

  2. Calendaring/Granulation: The compound is sheeted on two-roll mills at 60–80°C and either calendared into slabs (10–50 mm thick) or granulated for subsequent molding 15.

  3. Molding: Slabs are placed in molds and heated to 160–200°C under 50–150 bar pressure for 10–30 minutes. The temperature profile is critical: initial heating activates the peroxide (crosslinking onset), followed by blowing agent decomposition (foaming), with final cooling under pressure to stabilize cell structure 1. Steam injection or electric platens provide heating, with cycle times of 15–40 minutes depending on thickness 6.

  4. Post-Curing: Demolded foams are aged at ambient conditions for 24–72 hours to complete crosslinking reactions and relieve residual stresses, reducing shrinkage from 8–12% to 2–5% 1.

Process Optimization: Controlling the decomposition temperature differential (ΔT) between peroxide and blowing agent is essential. Optimal ΔT is 5–15°C, ensuring crosslinking precedes foaming to prevent cell collapse 17. Pre-polymer techniques, where EVA is partially crosslinked (gel content 20–40%) before foaming, improve initial tack and green strength, enabling complex geometries 1.

Injection Molding

Injection molding of EVA foam enables net-shape manufacturing of complex parts (e.g., shoe insoles, helmet liners) with minimal post-processing 1. Key parameters include:

  • Injection Temperature: 150–180°C, balancing melt viscosity (target: 10³–10⁴ Pa·s at shear rate 100 s⁻¹) and preventing premature foaming 1.
  • Mold Temperature: 140–170°C, maintained via electric heating or steam channels to activate foaming agents within the mold cavity 1.
  • Injection Pressure: 80–150 bar, with holding pressure 40–60% of injection pressure for 5–15 seconds to ensure cavity filling before expansion 1.
  • Cooling Time: 30–90 seconds, depending on part thickness (rule of thumb: 1 mm thickness requires 3–5 seconds cooling) 1.

Injection-molded EVA foams exhibit lower shrinkage (1–3%) compared to compression-molded counterparts due to constrained expansion within the mold 1.

Rotational Molding (Rotomolding)

An emerging technique for large, hollow EVA foam products (e.g., buoys, protective casings) involves rotomolding, where powdered EVA compound is charged into a heated, rotating mold (200–250°C) 6. The centrifugal force distributes material uniformly, and foaming occurs as the polymer melts and the blowing agent decomposes. Rotomolding eliminates size and shape constraints of compression molding, enabling products up to several meters in dimension with wall thicknesses of 5–50 mm 6. Cycle times range from 20–60 minutes, with cooling performed via water spray or air jets 6.

Extrusion Foaming

Continuous extrusion foaming is employed for EVA foam sheets, profiles, and wire/cable insulation. The process uses tandem extruders: the primary extruder (L/D ratio 25–35) melts and mixes the compound at 120–160°C, while a secondary extruder or static mixer incorporates the blowing agent (chemical or physical, e.g., isobutane, CO₂) under pressure (50–200 bar) 7. The melt exits through a die into atmospheric pressure, triggering rapid expansion. Crosslinking is achieved via electron beam irradiation (5–20 Mrad dose) post-extrusion or by incorporating peroxides that decompose during extrusion 7. Extrusion foaming yields densities of 0.03–0.15 g/cm³ with production rates of 50–500 kg/h 7.

Critical Process Variables:

  • Temperature Profile: Extruder zones are set to gradually increase temperature (e.g., Zone 1: 100°C, Zone 2: 130°C, Zone 3: 150°C, Die: 160°C) to ensure complete melting without premature blowing agent activation 7.
  • Screw Speed: 30–80 rpm, balancing residence time (3–5 minutes) for homogenization and shear heating 7.
  • Die Design: Slit dies (gap 1–5 mm) for sheets or annular dies for profiles, with die swell ratios of 1.2–1.8 depending on melt elasticity 7.

Physical And Mechanical Properties Of Ethylene Vinyl Acetate Foam

EVA foams exhibit a broad property spectrum tailored via formulation and processing. Representative properties for commercial grades include:

Density: 0.01–0.50 g/cm³ 4,14. Ultra-soft foams achieve densities as low as 0.01 g/cm³ (expansion ratio ~100×), while structural foams for automotive applications range 0.15–0.30 g/cm³ 1,13.

Hardness: 10–60 Shore 00 for soft foams 4; 20–70 Shore A for medium-density foams 1; up to 80 Shore A for high-density, high-filler formulations 13. Hardness correlates inversely with density and directly with VA content and crosslink density.

Tensile Strength: 0.5–3.5 MPa (ASTM D412), increasing with density and crosslink density 14. High-filler foams (60–80 pbw CaCO₃) exhibit tensile strengths of 1.8–2.5 MPa despite lower polymer content due to filler reinforcement 13.

Elongation At Break: 150–600%, with softer foams (Shore 00 <30) achieving >400% elongation, providing excellent energy absorption under impact 14.

Compression Set: 5–25% (ASTM D395, 22 h at 70°C) 1,4. Low compression set (<15%) is critical for footwear midsoles and sealing applications, achieved through optimized crosslink density (gel content 70–80%) and closed-cell content >90% 14.

Resilience (Rebound): 40–65% (ASTM D2632), reflecting the foam's capacity to recover energy after impact. Higher VA content and lower crosslink density enhance resilience 2.

Tear Strength: 3–12 kN/m (ASTM D624, Die C), important for durability in footwear and sports equipment 14.

**

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
COMTECH CHEMICAL CO. LTD.Medical and healthcare products requiring biocompatible, soft cushioning materials such as orthopedic supports, patient positioning pads, and therapeutic devices.Low Density EVA Medical FoamEVA-EMA blend formulation achieves hardness of 15-18 Shore A, specific gravity 0.16-0.18, with superior injection molding characteristics and reduced shrinkage from >5% to 1-3% through EMA incorporation.
ARKEMA FRANCESports equipment including shoe soles, protective gear, rackets, and golf balls requiring enhanced rebound capacity, low compression set, and performance across wide temperature ranges.PEBA-Modified EVA FoamIncorporation of polyamide-polyether block copolymers (PEBA) at 5-20 wt% enhances flexibility, resilience, and working temperature range, overcoming traditional EVA limitations in low-temperature flexibility and durability.
KEUM YANG CO. LTD.Environmentally conscious manufacturing of footwear midsoles, automotive interior materials, and construction insulation requiring reduced energy consumption and non-toxic production processes.Eco-Friendly Hydrazide Foaming SystemHydrazide-based foaming agents decompose at 110-155°C, reducing processing temperature by 20-30°C compared to azodicarbonamide, eliminating carcinogenic emissions while maintaining foam quality.
BRASKEM S.A.High-performance applications requiring recyclable materials including running shoe midsoles, automotive interior padding, carpet underlay, and construction gaskets where end-of-life material recovery is critical.Dynamically Crosslinkable EVA FoamDynamic crosslinking technology enables recyclability of EVA foam networks while maintaining high thermal resistance, toughness and resilience comparable to permanently crosslinked foams, addressing environmental challenges.
NIKE INC.Footwear manufacturing for midsoles and sock liners where significant foam scrap is generated during skiving, cutting and shaping operations, enabling circular economy implementation in athletic footwear production.EVA Foam Recycling ProcessProprietary recycling method enables reprocessing of EVA foam scrap from compression molding, injection molding and die-cutting operations, reducing waste from flashing and C-grade parts in slab stock production.
Reference
  • Ethylene Vinyl Acetate Based Polymer Foams with Low Density, Injection Preparation Method Thereof and a Material for Medical and Health-Care use
    PatentInactiveUS20090173906A1
    View detail
  • Foam of polymers comprising an ethylene-vinyl acetate (EVA) copolymer and/or a copolymer of ethylene and of alkyl (meth)acrylate and a copolymer containing polyamide blocks and polyether blocks
    PatentPendingUS20230357548A1
    View detail
  • A modified biodegradable ethylene vinyl acetate foam and a process for preparation thereoff
    PatentActiveIN202121021025A
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png